Related Experiment Videos
Aryl urea analogs with broad-spectrum antibacterial activity
Punit P Seth1, Ray Ranken, Dale E Robinson
1Ibis Therapeutics, A Division of Isis Pharmaceuticals, Inc., 1891 Rutherford Road, Carlsbad, CA 92008, USA. pseth@isisph.com
Bioorganic & Medicinal Chemistry Letters
|October 16, 2004
Summary
Novel aryl urea compounds demonstrate broad-spectrum antibacterial activity. These agents show promise in treating bacterial infections, including in vivo efficacy against septicemia.
Area of Science:
- Medicinal Chemistry
- Microbiology
- Pharmacology
Background:
- The rise of antibiotic resistance necessitates the development of new antibacterial agents.
- Aryl ureas represent a chemical class with potential for antimicrobial applications.
Purpose of the Study:
- To synthesize and characterize novel aryl urea analogs.
- To evaluate the broad-spectrum antibacterial efficacy of these compounds.
- To assess the in vivo performance of promising candidates.
Main Methods:
- Synthesis of diverse aryl urea analogs.
- Determination of minimum inhibitory concentrations (MICs) against Gram-positive and Gram-negative bacteria.
- In vivo efficacy testing in a murine model of bacterial septicemia.
Main Results:
- Numerous synthesized compounds displayed low micromolar MICs against a range of bacteria.
- Selected aryl urea analogs demonstrated significant efficacy in a lethal murine septicemia model.
- The study identified potent broad-spectrum antibacterial agents within the aryl urea class.
Conclusions:
- Novel aryl urea analogs are effective broad-spectrum antibacterial agents.
- These compounds hold potential for therapeutic development against bacterial infections.
- Further investigation into aryl urea derivatives is warranted for novel antibiotic discovery.